SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 773.45 |
| Enterprise Value ($M) | 621.47 |
| Book Value ($M) | 229.68 |
| Book Value / Share | 13.43 |
| Price / Book | 3.37 |
| NCAV ($M) | 226.95 |
| NCAV / Share | 13.27 |
| Price / NCAV | 3.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.54 |
| Return on Assets (ROA) | -1.27 |
| Return on Equity (ROE) | -1.94 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 15.12 |
| Current Ratio | 15.12 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 247.68 |
| Assets | 250.41 |
| Liabilities | 20.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2.45 |
| Operating Income | -126.37 |
| Net Income | -123.28 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -111.14 |
| Cash from Investing | 38.95 |
| Cash from Financing | 91.87 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Eventide Asset Management, Llc | 0.00 | ||
| 13G/A | Cormorant Asset Management, LP | 7.39 | ||
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 8.90 | ||
| 13G/A | Point72 Asset Management, L.P. | 8.60 | ||
| 13G/A | PFM Health Sciences, LP | 0.50 | ||
| 13G | Verition Fund Management LLC | 8.00 | ||
| 13G/A | Tri Locum Partners LP | 2.80 | ||
| 13G/A | Huang James | 0.00 | -100.00 | |
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Blackstone Holdings I/II GP L.L.C. | 0.80 | ||
| 13G/A | Adage Capital Partners Gp, L.l.c. | 8.40 | ||
| 13G/A | Kingdon Capital Management, L.l.c. | 2.90 | ||
| 13G/A | Sphera Funds Management Ltd. | 3.74 | -96.25 | |
| 13G/A | Cormorant Global Healthcare Master Fund, LP | 7.39 | ||
| 13D/A | Velan Capital Investment Management LP | 4.00 | 0.00 | |
| 13G/A | BlackRock Inc. | 4.70 | -1.46 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 38,295 | 64,882 | 59.02 | |
| 21,096 | 88,088 | 23.95 | |
| 32,383 | 702,982 | 4.61 | |
| 11,591 | 356,101 | 3.25 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PHVS – Pharvaris N.V. | PLRX – Pliant Therapeutics, Inc. |
| PMVP – PMV Pharmaceuticals, Inc. | PRLD – Prelude Therapeutics Incorporated |
| PRTA – Prothena Corporation plc |
Financial data and stock pages provided by
Fintel.io